XML 30 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Note 9 - Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Notes Tables  
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]

(in thousands, except for weighted-average data)

            

Stock Options

 

Shares

  

Weighted- Average Exercise Price

  

Weighted- Average Remaining Contractual Term (In Yrs)

 
             

Outstanding at January 1, 2023

  78  $381.00     

Forfeited or expired

  (7)  319.69     

Outstanding at March 31, 2023

  71  $376.68   7.1 
             

Vested and exercisable at March 31, 2023

  53  $456.01   6.6 
             

Vested and expected to vest at March 31, 2023

  69  $377.17   7.1 
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]

(in thousands, except for weighted-average data)

        

Restricted Stock Units

 

Shares

  

Weighted- Average Grant Date Fair Value

 
         

Outstanding at January 1, 2023

  11  $49.50 

Vested

  (3)  51.00 

Cancelled

  (1)  48.61 

Outstanding at March 31, 2023

  7  $49.31 
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
  

Three Months Ended March 31,

 

(in thousands)

 

2023

  

2022

 
         

Research and development

 $129  $235 

General and administrative

  156   535 

Total

 $285  $770 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

Three Months Ended March 31,

 
  

2022

 
     

Weighted average expected volatility

  106% 

Weighted average expected term (in years)

  6.9 

Weighted average risk-free interest rate

  1.70% 

Expected dividends

  -